1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Gabapentin Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Gabapentin Market Landscape
5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)
6 Global Gabapentin Market - Breakup by Dosage Form
6.1 Tablet
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2019-2024)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2025-2033)
6.2 Capsule
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2019-2024)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2025-2033)
6.3 Oral Solutions
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2019-2024)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2025-2033)
6.4 Attractive Investment Proposition by Dosage Form
7 Global Gabapentin Market - Breakup by Type
7.1 Generic
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2019-2024)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2025-2033)
7.2 Branded
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2019-2024)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2025-2033)
7.3 Attractive Investment Proposition by Type
8 Global Gabapentin Market - Breakup by Application
8.1 Epilepsy
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2019-2024)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2025-2033)
8.2 Neuropathic Pain
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2019-2024)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2025-2033)
8.3 Restless Legs Syndrome
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2019-2024)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2025-2033)
8.4 Others
8.4.1 Historical and Current Market Trends (2019-2024)
8.4.2 Market Forecast (2025-2033)
8.5 Attractive Investment Proposition by Application
9 Global Gabapentin Market - Breakup by Distribution Channel
9.1 Hospital Pharmacy
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2019-2024)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2025-2033)
9.2 Retail Pharmacy
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2019-2024)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2025-2033)
9.3 Online Pharmacy
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2019-2024)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2025-2033)
9.4 Attractive Investment Proposition by Distribution Channel
10 Global Gabapentin Market – Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Drivers
10.1.1.2 Historical and Current Market Trends (2019-2024)
10.1.1.3 Market Breakup by Dosage Form
10.1.1.4 Market Breakup by Type
10.1.1.5 Market Breakup by Application
10.1.1.6 Market Breakup by Distribution Channel
10.1.1.7 Key Players
10.1.1.8 Market Forecast (2025-2033)
10.1.2 Canada
10.1.2.1 Market Drivers
10.1.2.2 Historical and Current Market Trends (2019-2024)
10.1.2.3 Market Breakup by Dosage Form
10.1.2.4 Market Breakup by Type
10.1.2.5 Market Breakup by Application
10.1.2.6 Market Breakup by Distribution Channel
10.1.2.7 Key Players
10.1.2.8 Market Forecast (2025-2033)
10.2 Europe
10.2.1 Germany
10.2.1.1 Market Drivers
10.2.1.2 Historical and Current Market Trends (2019-2024)
10.2.1.3 Market Breakup by Dosage Form
10.2.1.4 Market Breakup by Type
10.2.1.5 Market Breakup by Application
10.2.1.6 Market Breakup by Distribution Channel
10.2.1.7 Key Players
10.2.1.8 Market Forecast (2025-2033)
10.2.2 France
10.2.2.1 Market Drivers
10.2.2.2 Historical and Current Market Trends (2019-2024)
10.2.2.3 Market Breakup by Dosage Form
10.2.2.4 Market Breakup by Type
10.2.2.5 Market Breakup by Application
10.2.2.6 Market Breakup by Distribution Channel
10.2.2.7 Key Players
10.2.2.8 Market Forecast (2025-2033)
10.2.3 United Kingdom
10.2.3.1 Market Drivers
10.2.3.2 Historical and Current Market Trends (2019-2024)
10.2.3.3 Market Breakup by Dosage Form
10. 2.3.4 Market Breakup by Type
10. 2.3.5 Market Breakup by Application
10. 2.3.6 Market Breakup by Distribution Channel
10.2.3.7 Key Players
10.2.3.8 Market Forecast (2025-2033)
10.2.4 Italy
10.2.4.1 Market Drivers
10.2.4.2 Historical and Current Market Trends (2019-2024)
10.2.4.3 Market Breakup by Dosage Form
10.2.4.4 Market Breakup by Type
10.2.4.5 Market Breakup by Application
10.2.4.6 Market Breakup by Distribution Channel
10.2.4.7 Key Players
10.2.4.8 Market Forecast (2025-2033)
10.2.5 Spain
10.2.5.1 Market Drivers
10.2.5.2 Historical and Current Market Trends (2019-2024)
10.2.5.3 Market Breakup by Dosage Form
10.2.5.4 Market Breakup by Type
10.2.5.5 Market Breakup by Application
10.2.5.6 Market Breakup by Distribution Channel
10.2.5.7 Key Players
10.2.5.8 Market Forecast (2025-2033)
10.2.6 Others
10.2.6.1 Historical and Current Market Trends (2019-2024)
10.2.6.2 Market Forecast (2025-2033)
10.3 Asia Pacific
10.3.1 China
10.3.1.1 Market Drivers
10.3.1.2 Historical and Current Market Trends (2019-2024)
10.3.1.3 Market Breakup by Dosage Form
10.3.1.4 Market Breakup by Type
10.3.1.5 Market Breakup by Application
10.3.1.6 Market Breakup by Distribution Channel
10.3.1.7 Key Players
10.3.1.8 Market Forecast (2025-2033)
10.3.2 Japan
10.3.2.1 Market Drivers
10.3.2.2 Historical and Current Market Trends (2019-2024)
10.3.2.3 Market Breakup by Dosage Form
10.3.2.4 Market Breakup by Type
10.3.2.5 Market Breakup by Application
10.3.2.6 Market Breakup by Distribution Channel
10.3.2.7 Key Players
10.3.2.8 Market Forecast (2025-2033)
10.3.3 India
10.3.3.1 Market Drivers
10.3.3.2 Historical and Current Market Trends (2019-2024)
10.3.3.3 Market Breakup by Dosage Form
10.3.3.4 Market Breakup by Type
10.3.3.5 Market Breakup by Application
10.3.3.6 Market Breakup by Distribution Channel
10.3.3.7 Key Players
10.3.3.8 Market Forecast (2025-2033)
10.3.4 South Korea
10.3.4.1 Market Drivers
10.3.4.2 Historical and Current Market Trends (2019-2024)
10.3.4.3 Market Breakup by Dosage Form
10.3.4.4 Market Breakup by Type
10.3.4.5 Market Breakup by Application
10.3.4.6 Market Breakup by Distribution Channel
10.3.4.7 Key Players
10.3.4.8 Market Forecast (2025-2033)
10.3.5 Australia
10.3.5.1 Market Drivers
10.3.5.2 Historical and Current Market Trends (2019-2024)
10.3.5.3 Market Breakup by Dosage Form
10.3.5.4 Market Breakup by Type
10.3.5.5 Market Breakup by Application
10.3.5.6 Market Breakup by Distribution Channel
10.3.5.7 Key Players
10.3.5.8 Market Forecast (2025-2033)
10.3.6 Indonesia
10.3.6.1 Market Drivers
10.3.6.2 Historical and Current Market Trends (2019-2024)
10.3.6.3 Market Breakup by Dosage Form
10.3.6.4 Market Breakup by Type
10.3.6.5 Market Breakup by Application
10.3.6.6 Market Breakup by Distribution Channel
10.3.6.7 Key Players
10.3.6.8 Market Forecast (2025-2033)
10.3.7 Others
10.3.7.1 Historical and Current Market Trends (2019-2024)
10.3.7.2 Market Forecast (2025-2033)
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Drivers
10.4.1.2 Historical and Current Market Trends (2019-2024)
10.4.1.3 Market Breakup by Dosage Form
10.4.1.4 Market Breakup by Type
10.4.1.5 Market Breakup by Application
10.4.1.6 Market Breakup by Distribution Channel
10.4.1.7 Key Players
10.4.1.8 Market Forecast (2025-2033)
10.4.2 Mexico
10.4.2.1 Market Drivers
10.4.2.2 Historical and Current Market Trends (2019-2024)
10.4.2.3 Market Breakup by Dosage Form
10.4.2.4 Market Breakup by Type
10.4.2.5 Market Breakup by Application
10.4.2.6 Market Breakup by Distribution Channel
10.4.2.7 Key Players
10.4.2.8 Market Forecast (2025-2033)
10.4.3 Others
10.4.3.1 Historical and Current Market Trends (2019-2024)
10.4.3.2 Market Forecast (2025-2033)
10.5 Middle East and Africa
10.5.1 Market Drivers
10.5.2 Historical and Current Market Trends (2019-2024)
10.5.3 Market Breakup by Dosage Form
10.5.4 Market Breakup by Type
10.5.5 Market Breakup by Application
10.5.6 Market Breakup by Distribution Channel
10.5.7 Market Breakup by Country
10.5.8 Key Players
10.5.9 Market Forecast (2025-2033)
10.6 Attractive Investment Proposition by Region
11 Global Gabapentin Market – Competitive Landscape
11.1 Overview
11.2 Market Structure
11.3 Market Share by Key Players
11.4 Market Player Positioning
11.5 Top Winning Strategies
11.6 Competitive Dashboard
11.7 Company Evaluation Quadrant
12 Profiles of Key Players
12.1 Alkem Laboratories Limited
12.1.1 Business Overview
12.1.2 Product Portfolio
12.1.3 Business Strategies
12.1.4 SWOT Analysis
12.1.5 Major News and Events
12.2 Amneal Pharmaceuticals LLC
12.2.1 Business Overview
12.2.2 Product Portfolio
12.2.3 Business Strategies
12.2.4 SWOT Analysis
12.2.5 Major News and Events
12.3 Apotex Inc.
12.3.1 Business Overview
12.3.2 Product Portfolio
12.3.3 Business Strategies
12.3.4 SWOT Analysis
12.3.5 Major News and Events
12.4 Aurobindo Pharma Limited
12.4.1 Business Overview
12.4.2 Product Portfolio
12.4.3 Business Strategies
12.4.4 SWOT Analysis
12.4.5 Major News and Events
12.5 Azurity Pharmaceuticals, Inc.
12.5.1 Business Overview
12.5.2 Product Portfolio
12.5.3 Business Strategies
12.5.4 SWOT Analysis
12.5.5 Major News and Events
12.6 Cipla Inc.
12.6.1 Business Overview
12.6.2 Product Portfolio
12.6.3 Business Strategies
12.6.4 SWOT Analysis
12.6.5 Major News and Events
12.7 Glenmark Pharmaceuticals Limited
12.7.1 Business Overview
12.7.2 Product Portfolio
12.7.3 Business Strategies
12.7.4 SWOT Analysis
12.7.5 Major News and Events
12.8 Pfizer Inc.
12.8.1 Business Overview
12.8.2 Product Portfolio
12.8.3 Business Strategies
12.8.4 SWOT Analysis
12.8.5 Major News and Events
12.9 Sun Pharmaceutical Industries Ltd.
12.9.1 Business Overview
12.9.2 Product Portfolio
12.9.3 Business Strategies
12.9.4 SWOT Analysis
12.9.5 Major News and Events
12.10 Teva Pharmaceutical Industries Ltd.
12.10.1 Business Overview
12.10.2 Product Portfolio
12.10.3 Business Strategies
12.10.4 SWOT Analysis
12.10.5 Major News and Events
12.11 Viatris Inc.
12.11.1 Business Overview
12.11.2 Product Portfolio
12.11.3 Business Strategies
12.11.4 SWOT Analysis
12.11.5 Major News and Events
12.12 Zydus Pharmaceuticals (USA) Inc. (Zydus LifeScience)
12.12.1 Business Overview
12.12.2 Product Portfolio
12.12.3 Business Strategies
12.12.4 SWOT Analysis
12.12.5 Major News and Events
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
13 Global Gabapentin Market - Industry Analysis
13.1 Drivers, Restraints, and Opportunities
13.1.1 Overview
13.1.2 Drivers
13.1.3 Restraints
13.1.4 Opportunities
13.1.5 Impact Analysis
13.2 Porters Five Forces Analysis
13.2.1 Overview
13.2.2 Bargaining Power of Buyers
13.2.3 Bargaining Power of Suppliers
13.2.4 Degree of Competition
13.2.5 Threat of New Entrants
13.2.6 Threat of Substitutes
13.3 Value Chain Analysis
14 Strategic Recommendations
15 Appendix